THC and Amphetamine Tolerance Did Not Share One Distribution Explanation in a Rat Study

A 1976 rat study compared tolerance to THC and amphetamine alongside drug distribution in brain fractions. Its authors proposed different explanations for the two drugs, illustrating why tolerance does not identify one common distribution mechanism.

Peak intensity and duration were different observations

After repeated THC administration, the initial response was approximately similar to that after one injection, while the effect disappeared during the subsequent observation period. A shorter effect is not necessarily a weaker peak, and the distinction changes what tolerance means in this context.

The study compared another drug under another regimen

Amphetamine tolerance was not associated with reduced unchanged-drug accumulation in the sampled subcellular fractions. That contrast did not establish one universal mechanism for either drug. Regimens and analytical measures differed, and the conclusions remain conditional.

Radiolabel measurements require chemical identity

The THC investigation assessed specific activities associated with labeled THC and its metabolites in brain fractions. A radiolabel-derived distribution is not automatically a selective measure of active parent drug or receptor occupancy. The authors' metabolic account should not be converted into a general rule about all THC tolerance.

Interpreting the evidence

The useful result separates effect duration, initial intensity and measured distribution. This historical animal study does not establish a human clearance rate or show that shorter observed effects necessarily mean lower impairment at every point after use.

Related reading: interpreting cannabis tolerance claims.

Research reference

Magour S; Coper H; Fähndrich C (1976). An attempt to correlate the development of tolerance to delta-9-tetrahydrocannabinol and d-amphetamine with their subcellular distribution in rat brain. Polish journal of pharmacology and pharmacy. PubMed research record.

This analysis draws on the supplied abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

A 2021 pilot study reported strong initial antinociceptive responses to THC and cannabinolic acid, followed by decreasing responses over subsequent days. The evidence concerns adult male mice and experimental mechanical and thermal tests. The study evaluated two nociceptive domains Mechanical and thermal responses were assessed after systemic intraperitoneal administration. Those…

Spread the love

Read Article: A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A 2001 mouse study found different opioid- and cannabinoid-receptor protein patterns across midbrain and spinal cord after short-term THC–morphine treatment. A statement about total receptor change would obscure those tissue-specific comparisons. The comparison included separate treatment groups Investigators assessed THC, morphine and their combination using Western blot measurements. Opioid-receptor protein…

Spread the love

Read Article: Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

A 2003 study found that selected kinase inhibitors reversed THC antinociceptive tolerance while others did not. One higher-dose intervention reduced THC's acute antinociceptive effect, illustrating a different outcome from reversing tolerance. The panel included useful negatives The study tested interventions directed at several kinases. Some did not affect tolerance under…

Spread the love

Read Article: A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us